Skip to main content
AssetsAnalyzer
Sectors
Technology
Financial Services
Consumer Cyclical
Healthcare
Energy
Real Estate
All sectors
Industries
Semiconductors
Software - Infrastructure
Internet Content & Information
Oil & Gas Integrated
Banks - Regional
Biotechnology
All industries
Ideas
Growth at a Reasonable PEG
High-Moat Low-Debt Winners
Dividend Aristocrat-Style
Hyper Growth Leaders
Cigar-Butts
Analyst Favorites
All ideas
Screeners
Stock screener
ETF screener
Want a detailed portfolio tracker?
Try Simply Wall St
Try Now
Sectors
Technology
Financial Services
Consumer Cyclical
Healthcare
Energy
Real Estate
All sectors
Industries
Semiconductors
Software - Infrastructure
Internet Content & Information
Oil & Gas Integrated
Banks - Regional
Biotechnology
All industries
Ideas
Growth at a Reasonable PEG
High-Moat Low-Debt Winners
Dividend Aristocrat-Style
Hyper Growth Leaders
Cigar-Butts
Analyst Favorites
All ideas
Screeners
Stock screener
ETF screener
Overview
Performance
Dividends
Correlations
HQL
NYSE
$16.93
abrdn Life Sciences Investors (HQL)
NYSE
$16.93
Net assets
$588M
Sharpe Ratio
2.15
Price Chart
Adjust inflation
Log
Export
Valuation
Net assets
$588M
Growth & Risk
Dividends 5Y CAGR
+9.07%
Beta (5Y)
0.71
Sharpe Ratio
2.15